Sunday, March 26th, 2017, 11:00-12:30

Hall 2, Palais des Congrès – Marseille Chanot

1956 – 2016: a long journey from the first successful BMT to the first successful patient-specific cell therapy in HSCT, approved by EC

Chairs Christian Chabannon - Head of Cell Therapy Facility at Institut Paoli-Calmettes (France)

Fabio Ciceri - Director of Hematology and BMT Unit, San Raffaele Scientific Institute (Italy)

Presentations

Christian Chabannon Introduction

Annalisa Ruggeri – Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint-Antoine (France) Safe post-transplant donor lymphocytes infusion in the era of T-cell engineering

Attilio Bondanza – Head of Innovative Immunotherapies Unit, San Raffaele Scientific Institute (Italy) CAR T-cell immunotherapy beyond lymphoid malignancies

Giuliana Ferrari – Head of Gene Transfer Into Stem Cells Unit, SR-TIGET, San Raffaele Scientific Institute (Italy) Gene therapy for beta-thalassemia

The purpose of this symposium is to outline what could be breakthrough treatments in the promising field of immune-gene therapy, on the 60th anniversary from the first successful BMT.